Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01005940 · ClinicalTrials.gov registry record · NA

Dental Device for Treatment of Sleep Apnea

A NA study, sponsored by Ulysses Magalang MD.

Completed
Registry status
NA
Development phase
20
Enrollment target

NCT01005940: Completed NA study, sponsored by Ulysses Magalang MD.

NCT01005940 is a NA study that has completed, run by Ulysses Magalang MD. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01005940, a NA study, has completed, sponsored by Ulysses Magalang MD.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

This study is being done to see if treatment of obstructive sleep apnea (OSA) with a mandibular advancement device (MAD) shows an increase in the quality of life. Many patients prefer to call them mandibular advancers, jaw advancers, jaw advancement splints, jaw advancement devices, anti-snoring mouthpieces, or oral appliances for the treatment of snoring and mild to moderate obstructive sleep apnea. The investigators will also see how helpful the mandibular advancement device is on insulin resistance.

Interventions

  • DEVICE Mandibular advancement device

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2010-01
Est. Completion 2014-12
Phase NA
Ulysses Magalang MD

2 total trials

What the finished NCT01005940 record still lists

NCT01005940 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Mandibular advancement device is the first listed.

NCT01005940 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01005940 about?

NCT01005940 is a clinical study titled "Dental Device for Treatment of Sleep Apnea". This study is being done to see if treatment of obstructive sleep apnea (OSA) with a mandibular advancement device (MAD) shows an increase in the quality of life. Many patients prefer to call them mandibular advancers, jaw advancers, jaw advancement splints, jaw advancement devices, anti-snoring mou...

What is the current status of trial NCT01005940?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2010-01. Estimated completion is 2014-12.

What interventions are being tested in trial NCT01005940?

The interventions under investigation include: Mandibular advancement device (DEVICE).

Who is sponsoring clinical trial NCT01005940?

This trial is sponsored by Ulysses Magalang MD, which has 2 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01005940's enrollment target sits among peer trials

20 1768th of 2000 higher than 140 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01005940, the US trial registry maintained by the National Library of Medicine. NCT01005940 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.